南模生物
(688265)
| 流通市值：45.06亿 | | | 总市值：45.06亿 |
| 流通股本：7796.35万 | | | 总股本：7796.35万 |
| 报告期 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 一、营业总收入 | 195,763,143.74 | 88,396,140.55 | 381,239,513.99 | 264,848,483.4 |
| 营业收入 | 195,763,143.74 | 88,396,140.55 | 381,239,513.99 | 264,848,483.4 |
| 二、营业总成本 | 183,919,911.5 | 94,524,575.57 | 398,788,336.81 | 296,662,616.31 |
| 营业成本 | 93,757,494.7 | 45,096,068.5 | 207,247,055.01 | 149,290,455.67 |
| 税金及附加 | 1,322,972.21 | 663,981.16 | 3,863,669.48 | 2,202,404.24 |
| 销售费用 | 29,477,290.08 | 15,287,149.06 | 58,012,150.27 | 45,627,932.27 |
| 管理费用 | 16,607,278.94 | 13,094,716.15 | 53,595,460.75 | 39,826,209.06 |
| 研发费用 | 41,588,634.82 | 19,755,542.27 | 74,981,116.58 | 57,232,634.76 |
| 财务费用 | 1,166,240.75 | 627,118.43 | 1,088,884.72 | 2,482,980.31 |
| 其中:利息费用 | 1,390,821.72 | 718,427.15 | 3,801,010.43 | 3,054,903.99 |
| 其中:利息收入 | -1,313,862.02 | 599,033.92 | 1,834,994.79 | 1,191,560.45 |
| 三、其他经营收益 | | | | |
| 加:公允价值变动收益 | 8,610,993.1 | 5,422,190.03 | 19,301,458.69 | 15,840,269.92 |
| 加:投资收益 | 1,181,013.5 | 104,414.02 | 1,041,919.05 | 714,176.57 |
| 资产处置收益 | - | - | 20,207.24 | -7,835.19 |
| 资产减值损失(新) | -1,712,063.32 | -1,288,538.88 | -844,076.86 | -1,332,490.25 |
| 信用减值损失(新) | -6,971,157.24 | -2,431,685.83 | -4,746,341.63 | -7,741,601.29 |
| 其他收益 | 4,721,030.86 | 2,082,310.25 | 5,563,627.94 | 3,532,676.1 |
| 四、营业利润 | 17,673,049.14 | -2,239,745.43 | 2,787,971.61 | -20,808,937.05 |
| 加:营业外收入 | 356.04 | - | 57,335.39 | 45,912.99 |
| 减:营业外支出 | 98,599.2 | 50,100 | 116,677.41 | 55,474.79 |
| 五、利润总额 | 17,574,805.98 | -2,289,845.43 | 2,728,629.59 | -20,818,498.85 |
| 减:所得税费用 | -592,569.02 | -1,323,026.38 | -3,766,874.46 | -5,623,142.6 |
| 六、净利润 | 18,167,375 | -966,819.05 | 6,495,504.05 | -15,195,356.25 |
| (一)按经营持续性分类 | | | | |
| 持续经营净利润 | 18,167,375 | -966,819.05 | 6,495,504.05 | -15,195,356.25 |
| (二)按所有权归属分类 | | | | |
| 归属于母公司股东的净利润 | 18,167,375 | -966,819.05 | 6,495,504.05 | -15,195,356.25 |
| 扣除非经常损益后的净利润 | 5,914,262.8 | -7,341,175.29 | -15,509,640.43 | -32,270,917.07 |
| 七、每股收益 | | | | |
| (一)基本每股收益 | 0.23 | -0.01 | 0.08 | -0.2 |
| (二)稀释每股收益 | 0.23 | -0.01 | 0.08 | -0.2 |
| 八、其他综合收益 | -62,914.59 | -43,265.75 | 341,360.49 | -227,518.56 |
| 归属于母公司股东的其他综合收益 | -62,914.59 | -43,265.75 | 341,360.49 | -227,518.56 |
| 九、综合收益总额 | 18,104,460.41 | -1,010,084.8 | 6,836,864.54 | -15,422,874.81 |
| 归属于母公司股东的综合收益总额 | 18,104,460.41 | -1,010,084.8 | 6,836,864.54 | -15,422,874.81 |
| 公告日期 | 2025-08-29 | 2025-04-29 | 2025-04-29 | 2024-10-31 |
| 审计意见(境内) | | | 标准无保留意见 | |